Biotechs going to market alone must learn to go global
The biotech funding rebound presents a strategic choice for small drug developers that was not available during the post-pandemic slump.…
Category: biotechs
US biotechs take lion’s share of $54.5B VC money raised since 2025
Biopharma has collected $54.5 billion across 959 rounds globally since the start of 2025 through 2026’s third quarter, with U.S.…